Gouty Arthritis (Gout) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Gouty Arthritis Pipeline Drugs Market Report Overview

Gout is a type of arthritis where swelling and severe pain develops in joints, especially at the base of the big toe. Gout occurs when uric acid builds up in the blood and causes inflammation in the joints.  Symptoms include sudden onset of joint pain, joint swelling, heat in the affected area, and joint redness. Risk factors include obesity, high alcohol intake, injury to joints, long-standing kidney disease, and high intake of foods rich in purines.

The Gouty Arthritis (Gout) pipeline drugs market research report covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. The report offers details on the development of products for the treatment of Gouty Arthritis (Gout) in different stages including Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery, and Unknown.

For additional insights on gouty arthritis pipeline drugs market, https://www.globaldata.com/store/enquiry-before-buying/?report=3168230download a free report sample

Gouty Arthritis Pipeline Drugs Market Segmentation by Targets

The key targets of the gouty arthritis pipeline drugs market are Solute Carrier Family 22 Member 12, Xanthine Dehydrogenase/Oxidase, Uric Acid, Urate Transporter, Interleukin 1 Beta, Interleukin 1 Receptor, NACHT LRR And PYD Domains Containing Protein 3, Caspase 1, Dual Specificity Mitogen Activated Protein Kinase Kinase 2, Interleukin 1 Receptor Associated Kinase 1, Interleukin 1 Receptor Associated Kinase 4, Interleukin 18 Receptor 1, Interleukin 18 Receptor Accessory Protein, Mitogen Activated Protein Kinase Kinase Kinase 7, NADPH Oxidase, Protein S100 A9, and Sphingosine 1-Phosphate Receptor 1

Gouty Arthritis Pipeline Drugs Market Analysis, by Targets

For more targets insights on gouty arthritis pipeline drugs market, download a free report sample

Gouty Arthritis Pipeline Drugs Market Segmentation by Mechanism of Actions

The key mechanism of actions of the gouty arthritis pipeline drugs market are Solute Carrier Family 22 Member 12 Inhibitor, Xanthine Dehydrogenase/Oxidase Inhibitor, Uric Acid Depletor, Urate Transporter Inhibitor, Interleukin 1 Beta Inhibitor, Interleukin 1 Receptor Antagonist, NACHT LRR And PYD Domains Containing Protein 3 Inhibitor, Caspase 1 Inhibitor, Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Inhibitor, Interleukin 1 Receptor Associated Kinase 1 Inhibitor, Interleukin 1 Receptor Associated Kinase 4 Inhibitor, Interleukin 18 Receptor 1 Antagonist, Interleukin 18 Receptor Accessory Protein Inhibitor, Mitogen Activated Protein Kinase Kinase Kinase 7 Inhibitor, NADPH Oxidase Inhibitor, Protein S100 A9 Inhibitor, and Sphingosine 1-Phosphate Receptor 1 Agonist

Gouty Arthritis Pipeline Drugs Market Analysis, by MoA

For more insights on MoA, download free report sample

Gouty Arthritis Pipeline Drugs Market Segmentation by Route of Administration

The key route of administration in the gouty arthritis pipeline drugs market are oral, intramuscular, intravenous, parenteral, subcutaneous, topical, and transdermal.

Gouty Arthritis Pipeline Drugs Market Analysis, by RoA

For additional RoA insights on gouty arthritis pipeline drugs market, download the free report sample

Gouty Arthritis Pipeline Drugs Market Segmentation by Molecule Types

The key molecule types in the gouty arthritis pipeline drugs market include small molecule, recombinant enzyme, monoclonal antibody, recombinant protein, antisense RNAi oligonucleotide, gene-modified cell therapy, antisense oligonucleotide, biologic, enzyme, and fusion protein.

Gouty Arthritis Pipeline Drugs Market Analysis, by Molecule Types

For more molecule type insights, download free report sample

Competitive Landscape

Some of the key companies in the gouty arthritis pipeline drugs market are Fuji Yakuhin Co Ltd, Tonghua Dongbao Pharmaceutical Co Ltd, Jiangsu Atom Bioscience and Pharmaceutical Co Ltd, Jiangsu Hengrui Medicine Co Ltd, Acquist Theraputics Inc, C&C Research Laboratories, Fochon Pharmaceutical Ltd, Horizon Therapeutics Plc, Nippon Chemiphar Co Ltd, and Teijin Pharma Ltd.

Gouty Arthritis Pipeline Drugs Market Analysis, by Companies

For more information on leading companies, download a free report sample

Gouty Arthritis Pipeline Drugs Market Report Overview

Scope

• The pipeline guide provides a snapshot of the global therapeutic landscape of Gouty Arthritis (Gout) (Musculoskeletal Disorders).
• The pipeline guide reviews pipeline therapeutics for Gouty Arthritis (Gout) (Musculoskeletal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration to discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Gouty Arthritis (Gout) (Musculoskeletal Disorders) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Gouty Arthritis (Gout) (Musculoskeletal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews the latest news related to pipeline therapeutics for Gouty Arthritis (Gout) (Musculoskeletal Disorders)

Reasons to Buy

• Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
• Recognize emerging players with a potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Find and recognize significant and varied types of therapeutics under development for Gouty Arthritis (Gout) (Musculoskeletal Disorders).
• Classify potential new clients or partners in the target demographic.
• Develop tactical initiatives by understanding the focus areas of leading companies.
• Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
• Formulate corrective measures for pipeline projects by understanding Gouty Arthritis (Gout) (Musculoskeletal Disorders) pipeline depth and focus of Indication therapeutics.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
• Adjust the therapeutic portfolio by recognizing discontinued projects and understanding from the know-how what drove them from the pipeline.